ELEVANCE HEALTH INC (A58.DE) Stock Price, Forecast & Analysis
Europe - FRA:A58 - US0367521038 - Common Stock
A58.DE Key Statistics, Chart & Performance
The current stock price of A58.DE is 274.3 EUR. In the past month the price decreased by -2.49%.
A58.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1UNH.MI | UNITEDHEALTH GROUP INC | 16.29 | 268.26B | ||
| UNH.DE | UNITEDHEALTH GROUP INC | 16.28 | 268.03B | ||
| 1CNC.MI | CENTENE CORP | 8.97 | 15.41B |
Related stock screener links
About A58.DE
Company Profile
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Company Info
ELEVANCE HEALTH INC
220 Virginia Avenue
Indianapolis INDIANA US
Employees: 104200
Phone: 18003311476
ELEVANCE HEALTH INC / A58.DE FAQ
Can you describe the business of ELEVANCE HEALTH INC?
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Can you provide the latest stock price for ELEVANCE HEALTH INC?
The current stock price of A58.DE is 274.3 EUR. The price decreased by -3.21% in the last trading session.
Does A58 stock pay dividends?
ELEVANCE HEALTH INC (A58.DE) has a dividend yield of 2.12%. The yearly dividend amount is currently 5.67.
What is the ChartMill technical and fundamental rating of A58 stock?
A58.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the upcoming earnings date for ELEVANCE HEALTH INC?
ELEVANCE HEALTH INC (A58.DE) will report earnings on 2026-01-21, after the market close.
What is the ownership structure of ELEVANCE HEALTH INC (A58.DE)?
You can find the ownership structure of ELEVANCE HEALTH INC (A58.DE) on the Ownership tab.
A58.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to A58.DE.
A58.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to A58.DE. There are concerns on the financial health of A58.DE while its profitability can be described as average.
A58.DE Financial Highlights
Over the last trailing twelve months A58.DE reported a non-GAAP Earnings per Share(EPS) of 26.55. The EPS decreased by -11.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.84% | ||
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| Debt/Equity | 0.71 |
A58.DE Forecast & Estimates
28 analysts have analysed A58.DE and the average price target is 340.73 EUR. This implies a price increase of 24.22% is expected in the next year compared to the current price of 274.3.
For the next year, analysts expect an EPS growth of -8.41% and a revenue growth 12.47% for A58.DE